FDA Approves First Gene Therapy for Spinal Muscular Atrophy

Patients treated with Zolgensma have shown improvement in reaching developmental motor milestones

Source link

Related posts

Survival Worse for Nonwhite Children With Hodgkin Lymphoma


Recommended Childhood and Adolescent Immunization Schedules: United States, 2019


CDC: Look for Early Symptoms of AFM


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy